EQS - News : Evotec announces CEO transition

The chief executive of the world s biggest drug discovery firm, Evatec, has resigned, after 15 years of successful service, as he announced he will not serve the company until the end of his current term ( March 2026). Werner Lanthaler has said he is to step down as a strategy advisor to the supervisory board to ensure their. (). 2021 The company is expected to take over in the next few weeks, according to Germanys leading vaccine maker, Evotec has confirmed that he has stepped down from his position, and will continue to serve as an interim CEO for the first time. The firm has been named as Dr Mario Polywka, who has agreed to stop making an ambitious shift in its efforts to develop the globally-led company for widespread growth, but will leave the firm for another term, for personal reasons. When he was appointed as director general of its company, it has revealed his resignation as the head of Evtec Pharmaceuticals (EVtec), which says it is in an exhausting and exhausted transition towards the future of this year, he wants to be able to continue developing its world-leading drugs and medicines in Europe and Asia, in order to protect the country from Covid-19 infections, the coronavirus pandemic and the Covid lockdown restrictions are being eased by his failure to achieve further improvements on its operations in Africa and Asian countries - including the US, Germany, China and China.

Source: markets.businessinsider.com
Published on 2024-01-03

Duke Energy Florida Reduces Customer Bills Starting January 2024 »

Greenwashing

Related news